Skip to content
About Us
Our Approach
Pipeline
Clinical Trials
Overview
Our Trials
Why LAM-001
Expanded Access
Contact
Investors
Overview
News
Events
SEC Filings
Corporate Governance
Stock Information
FAQs
Steven Nathan, M.D., F.C.C.P.
Schar Chair, Advanced Lung Disease and Lung Transplant Program, Inova Health System. Professor of Education, University of Virginia
Meet the Scientific Advisory Board
About Us
Our Approach
Pipeline
Clinical Trials
Overview
Our Trials
Why LAM-001
Expanded Access
Contact
Investors
Overview
News
Events
SEC Filings
Corporate Governance
Stock Information
FAQs
About Us
Our Approach
Pipeline
Clinical Trials
Overview
Our Trials
Why LAM-001
Expanded Access
Contact
Investors
Overview
News
Events
SEC Filings
Corporate Governance
Stock Information
FAQs